William Blair & Company’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

William Blair & Company’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,000	Closed	-$10.5K	–	1887
2023 Q1	$10.5K	Hold	15,000	–	–	﹤0.01%	1723
2022 Q4	$13.5K	Buy	+15,000	New	+$43.5K	﹤0.01%	1716

William Blair & Company's STSA Position: Q2 2023 in Review

William Blair & Company sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 15,000 shares — an estimated $10.5K sold.

William Blair & Company first reported a position in STSA in Q4 2022 and held it in 2 quarters. The position peaked at $13.5K in Q4 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

William Blair & Company reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
William Blair & Company sold 15,000 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $10.5K.
William Blair & Company first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
William Blair & Company's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $13.5K in Q4 2022.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.